Home / Resource Library / Loncastuximab Tesirine and Ibrutinib Combination Shows Promise in R/R DLBCL and MCLLoncastuximab Tesirine and Ibrutinib Combination Shows Promise in R/R DLBCL and MCL PPLC 2021